Data as of Apr 17
| +0.35 / +1.04%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 40.00, with a high estimate of 45.00 and a low estimate of 35.00. The median estimate represents a +17.58% increase from the last price of 34.02.
The current consensus among 2 polled investment analysts is to Buy stock in Cantel Medical Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.